Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Silene Biotech is a biotechnology company focused on personalized preventive medicine through advanced stem cell banking and cryopreservation. Based in Seattle, the company offers services to collect, process, and store an individual's young, healthy stem cells for future therapeutic use in regenerative medicine and anti-aging treatments. By leveraging proprietary technology, Silene aims to provide a biological insurance policy, ensuring that patients have access to their own high-quality cells as they age. Their business model bridges the gap between consumer health and clinical cell therapy. The company specifically targets the preservation of mesenchymal stem cells and the creation of induced pluripotent stem cells. This proactive approach allows individuals to secure their genetic assets before the onset of age-related cellular degradation.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Silene Biotech.